MLTX Competitors & Alternatives
Compare MoonLake Immunotherapeutics with similar stocks in the same industry
Biotechnology
MLTX
Main Stock$21.67
Tradestie Score
67
Market Cap
$448.32M
Analyst Upside
+27.4%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AUPH
Aurinia Pharmaceuticals Inc
|
$17.74
|
$1.50B | 8.1 | 66 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$45.05
|
$1.50B | - | 56 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$16.53
|
$1.49B | - | 55 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$27.90
|
$1.43B | - | 57 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$14.90
|
$1.42B | - | 62 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$19.62
|
$1.35B | - | 61 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$39.04
|
$1.32B | - | 57 | Compare |
|
MPLT
MPLT
|
$29.62
|
$1.31B | - | 54 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$7.18
|
$1.29B | 99.3 | 63 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$31.57
|
$1.29B | - | 63 | Compare |
More MLTX Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry